Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prenoxad 2mg/2ml solution for injection pre-filled syringes
1902070Q0BDAAAF
|
Prenoxad | Naloxone hydrochloride | Other Drugs and Preparations | 35 |
|
Naloxone 2mg/2ml solution for injection pre-filled syringes
1902070Q0AAAFAF
|
Naloxone hydrochloride (Poisoning Antidote) | Naloxone hydrochloride | Other Drugs and Preparations | 25 |
|
Naloxone 400micrograms/1ml solution for injection ampoules
1902070Q0AAAAAA
|
Naloxone hydrochloride (Poisoning Antidote) | Naloxone hydrochloride | Other Drugs and Preparations | 9 |
|
Naloxone 1.8mg/0.1ml nasal spray unit dose
1902070Q0AAAIAI
|
Naloxone hydrochloride (Poisoning Antidote) | Naloxone hydrochloride | Other Drugs and Preparations | 5 |
|
Naloxone 1.26mg/0.1ml nasal spray unit dose
1902070Q0AAAJAJ
|
Naloxone hydrochloride (Poisoning Antidote) | Naloxone hydrochloride | Other Drugs and Preparations | 2 |
|
Naloxone 2mg/5ml inj Minijet pre-filled syringes
1902070Q0BCACAG
|
Minjet naloxone | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
|
Naloxone 2mg/5ml solution for injection pre-filled syringes
1902070Q0AAAGAG
|
Naloxone hydrochloride (Poisoning Antidote) | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
|
Naloxone 400micrograms/1ml inj Minijet pre-filled syringes
1902070Q0BCAAAD
|
Minjet naloxone | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
|
Naloxone 400micrograms/1ml inj pre-filled syringes
1902070Q0AAADAD
|
Naloxone hydrochloride (Poisoning Antidote) | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
|
Naloxone 40micrograms/2ml solution for injection ampoules
1501070G0AAAAAA
|
Naloxone hydrochloride (Anaesthesia) | Naloxone hydrochloride | Anaesthesia | No data available |
|
Naloxone 800micrograms/2ml inj Minijet pre-filled syringes
1902070Q0BCABAH
|
Minjet naloxone | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
|
Naloxone 800micrograms/2ml inj pre-filled syringes
1902070Q0AAAHAH
|
Naloxone hydrochloride (Poisoning Antidote) | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
|
Narcan 400micrograms/1ml solution for injection ampoules
1902070Q0BBAAAA
|
Narcan | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
|
Narcan Neonatal 40micrograms/2ml inj ampoules
1501070G0BBAAAA
|
Narcan Neonatal | Naloxone hydrochloride | Anaesthesia | No data available |
|
Nyxoid 1.8mg/0.1ml nasal spray 0.1ml unit dose
1902070Q0BEAAAI
|
Nyxoid | Naloxone hydrochloride | Other Drugs and Preparations | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.